Taek-Geun Kim
Vorstandsvorsitzender bei Korea Stem Cell Bank Co., Ltd.
Profil
Taek-Geun Kim is currently the Chief Executive Officer at Korea Stem Cell Bank Co., Ltd.
Prior to this, he worked as a Director at BIOVILL Co., Ltd.
He completed his undergraduate degree at Korea University.
Aktive Positionen von Taek-Geun Kim
| Unternehmen | Position | Beginn |
|---|---|---|
Korea Stem Cell Bank Co., Ltd.
 Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Taek-Geun Kim
| Unternehmen | Position | Ende |
|---|---|---|
| KSCB CO LTD | Direktor/Vorstandsmitglied | 27.03.2015 |
Ausbildung von Taek-Geun Kim
| Korea University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BIOVILL Co., Ltd.
 BIOVILL Co., Ltd. Industrial SpecialtiesProcess Industries BIOVILL Co., Ltd. engages in the manufacture and sale of functional materials. Its products include coloring materials for plastics, inks for plastic printing, surface treatment materials, polyvinyl compound, frame structure, and other products. The company was founded in April 1976 and is headquartered in Yangsan-si, South Korea. | Process Industries |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Health Technology |
